In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Area of Science:

• Immunology
• Cellular Biology
• In vivo Assays

Background:

• Current methods for assessing antigen-specific killing are limited to in vitro settings or infection models.
• There is a need for a protocol to measure antigen-specific killing directly in vivo, independent of infection or tumor growth.

Purpose of the Study:

• To describe a novel protocol for detecting antigen-specific killing of target cells by CD8+ T cells in vivo.
• To provide a method for rapid assessment of cytotoxic T lymphocyte (CTL) potential.
• To establish an assay accessible to most researchers via flow cytometry.

Main Methods:

• The protocol merges a vaccination model with a traditional CFSE-labeled target cell killing assay.
• Antigen-specific killing is detected by analyzing target cell lysis mediated by CD8+ T cells.
• The assay utilizes flow cytometry for quantitative readout.

Main Results:

• The developed protocol allows for the detection of antigen-specific CTL killing in vivo.
• The assay provides a direct and rapid assessment of CTL potential, not reliant on tumor growth or infection.
• The method is adaptable to various antigens and readily accessible due to its flow cytometry-based readout.

Conclusions:

• This protocol offers a valuable tool for quickly assessing in vivo CTL killing function.
• The method overcomes limitations of existing assays by enabling antigen-specific killing measurement without infection.
• Further validation is needed to determine optimal timelines and peptide concentrations for specific research hypotheses.